Shenmai injection quality evaluation method based on anaphylactic reaction risk prediction
The invention relates to a Shenmai injection quality evaluation method based on anaphylactic reaction risk prediction, which comprises the following steps: extracting quality inspection data of a Shenmai injection production batch, including an inspection item result, a fingerprint item result and a...
Gespeichert in:
Hauptverfasser: | , , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The invention relates to a Shenmai injection quality evaluation method based on anaphylactic reaction risk prediction, which comprises the following steps: extracting quality inspection data of a Shenmai injection production batch, including an inspection item result, a fingerprint item result and a content determination item result, and defining all the results as variables; carrying out weighted calculation on the variables to obtain an anaphylactic reaction risk prediction value of the Shenmai injection of the production batch; and performing quality evaluation on the production batch of Shenmai injection based on the allergic reaction risk prediction value, and if the risk prediction value is higher than a set threshold value, identifying the production batch of Shenmai injection as a high-risk batch of allergic reaction. According to the method disclosed by the invention, quality inspection data and clinical anaphylactic reaction information in the production of the Shenmai injection are closely associat |
---|